Venous thromboembolism (VTE) is rare in healthy children, but is an increasing problem in
children with underlying medical conditions. Pediatric VTE encompasses a highly …

Venous thromboembolism (VTE) in children can lead to significant morbidity and mortality.
Traditionally, treatment for thrombotic events in pediatric patients has been limited mainly to …

Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein
thrombosis, is a condition characterized by abnormal blood clot formation in the pulmonary …

Interventions: Intravenous antibiotics along with anticoagulants and laparoscopic
appendectomy Outcomes: After 1 month, a follow-up ultrasonography revealed full …

Background Little evidence is available for treatment of pediatric venous thromboembolism
(VTE). Large randomized controlled trials are challenging in children. Current antithrombotic …

Pulmonary arterial hypertension (PAH) is a devastating illness causing already significant
morbidity in childhood. Currently approved treatment options for children comprise the …

Pediatric antiphospholipid syndrome (APS) is a rare acquired multisystem autoimmune
thromboinflammatory condition characterized by thrombotic and non-thrombotic clinical …

Special aspects of anticoagulation in children include the different epidemiology of
thrombosis, developmental changes in the coagulation system, age-dependent …

Children with cardiac diseases suffer from significant morbidity and mortality secondary to
thromboembolic complications. Anticoagulant agents currently used for thromboprophylaxis …

Pulmonary arterial hypertension (PAH) is a rare and devastating disease of the pulmonary
vasculature with a high morbidity and mortality rate in infants and children. Currently …